Skip to main content

Shares in the S&P 500 Bank Index rose 2.6 per cent on Friday after the U.S. Federal Reserve approved the capital plans of the biggest U.S. banks, giving them a clean bill of health.

M&T Bank Corp. was the only one of the index’s stocks down slightly as at least one analyst said its payout plan was lighter than expected. JPMorgan Chase & Co. and Bank of America were the group’s biggest boosts with gains over 3 per cent, followed by advances of over 2 per cent for Wells Fargo & Co and Citigroup.

All 18 banks undergoing the Fed’s annual stress test were given the all-clear, although the central bank placed conditions on Credit Suisse’s U.S. operations after finding weaknesses in its capital planning processes.

Story continues below advertisement

The Fed’s stamp of approval for Deutsche Bank was a major boost since it flunked the test in 2015, 2016 and 2018.

JPMorgan and Capital One passed the test though both had to pare back their capital plans, after initial plans showed that each would see capital levels drop below regulatory minimums under a severe economic downturn, according to a senior Fed official.

Jefferies analyst Ken Usdin estimated that the average bank would be returning about 10.5 per cent of its market capitalization in dividends and buybacks from the third quarter of 2019 to the second quarter of 2020. He said total payout ratios for universals averages at about 125 per cent of net income estimates.

Bank of America, Bank of New York Mellon, JPMorgan and Northern Trust Corp. had notably larger payouts than Mr. Usdin’s estimates, while Capital One, Discover Financial Services and M&T were lightest compared with his estimates.

Goldman Sachs, Morgan Stanley and State Street Corp., which received conditional passes last year, passed without conditions this year. Goldman Sachs, which is not in the S&P Bank Index was up more than 3 per cent.

Report an error
Tickers mentioned in this story
Unchecking box will stop auto data updates
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

Cannabis pro newsletter